Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-9788
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications ; volume:3 ; number:1 ; day:10 ; month:3 ; year:2016 ; pages:115-120 ; date:3.2016
Drugs - real world outcomes ; 3, Heft 1 (10.3.2016), 115-120, 3.2016
- Urheber
-
Hainsworth, John D.
- Beteiligte Personen und Organisationen
-
Anthony Greco, F.
SpringerLink (Online service)
- DOI
-
10.1007/s40801-016-0064-7
- URN
-
urn:nbn:de:1111-2016033010767
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:57 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hainsworth, John D.
- Anthony Greco, F.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
ALK-Negative Anaplastic Large-Cell Lymphoma Diagnosed on Liver Biopsy in a Child Presenting with Nonresolving Pyrexia
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement
ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
ALK-Negative Anaplastic Large-Cell Lymphoma Diagnosed on Liver Biopsy in a Child Presenting with Nonresolving Pyrexia
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement
ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center
Anaplastic large cell lymphoma ALK negative vs. peripheral T cell lymphoma (NOS) - diagnostic dilemma
Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
Central nervous system ALK-negative anaplastic large cell lymphoma with IRF4/DUSP22 rearrangement
The role of Anaplastic Lymphoma Kinase (ALK) and CEBPβ-regulated miRNAs in ALK+ Anaplastic Large Cell Lymphoma
ALK-Negative Anaplastic Large-Cell Lymphoma Diagnosed on Liver Biopsy in a Child Presenting with Nonresolving Pyrexia
Dissecting ALK-specific CD4 T Cell Responses for ALK-positive Anaplastic Large Cell Lymphoma Immunotherapy
Targeting Anaplastic Lymphoma Kinase (ALK) in Rhabdomyosarcoma (RMS) with the Second-Generation ALK Inhibitor Ceritinib
Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma
Status of the anaplastic lymphoma kinase (ALK) gene in inflammatory breast carcinoma
Combination of conventional immunohistochemistry and qRT-PCR to detect ALK rearrangement
ALK rearrangement: a high-frequency alteration in ovarian metastasis from lung adenocarcinoma
Role of ALK Inhibitors in Anaplastic Large Cell LymphomaExperience from an Indian Center